Advertisement

Corrigendum to “Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology” [International Journal of Cardiology Volume 364, 1 October 2022, Pages 169–177].

Published:November 04, 2022DOI:https://doi.org/10.1016/j.ijcard.2022.10.162
      The author Lia Crotti, in respect of the rules of Italian Ministry of Health, would like to correct her affiliation as follows:
      h Center for Cardiac Arrhythmias of Genetic Origin, Istituto Auxologico Italiano, IRCCS, Milan, Italy.
      w Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
      The authors would like to apologise for any inconvenience caused.

      Linked Article

      • Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology
        International Journal of CardiologyVol. 364
        • Preview
          Molecular genetic testing is an increasingly available test to support the clinical diagnosis of inherited cardiovascular diseases through identification of pathogenic gene variants and to make a preclinical genetic diagnosis among proband's family members (so-called “cascade family screening”). In athletes, the added value of molecular genetic testing is to assist in discriminating between physiological adaptive changes of the athlete's heart and inherited cardiovascular diseases, in the presence of overlapping phenotypic features such as ECG changes, imaging abnormalities or arrhythmias (“grey zone”).
        • Full-Text
        • PDF